Skip to content
Homepage
Category:
Press Releases
Posted Date:
June 7, 2026
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
AMERICAN DIABETES ASSOCIATION
June 7, 2026
Investors Worldwide Are Discovering New Opportunities In Lithium, Rare Earth Minerals, and EV Technology
Elektros, Inc.
June 7, 2026
Billionaires, Millionaires, Microcap and Penny Stock Investors: The Global Race for Lithium, Rare Earth Minerals and EV Technology Is Accelerating
Elektros, Inc.
June 7, 2026
Rosen Law Firm Encourages DNOW Inc. Investors to Inquire About Securities Class Action Investigation – DNOW
THE ROSEN LAW FIRM, P. A.
June 7, 2026
Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist
Antag Therapeutics
June 7, 2026
Prev
1
…
2,461
2,462
2,463
